Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
821
archived clinical trials in
Contraception

A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Teva Investigational Site
983
mi
from
Uniontown, PA
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
983
mi
from
Uniontown, PA
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Aeroallergy Research Labs of Savannah
1026
mi
from
Savannah, GA
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Updated: 1/1/1970
Aeroallergy Research Labs of Savannah
1026
mi
from
Savannah, GA
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Teva Investigational Site
518
mi
from
Jackson, TN
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
518
mi
from
Jackson, TN
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Teva Investigational Site
574
mi
from
Houston, TX
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
574
mi
from
Houston, TX
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Teva Investigational Site
1122
mi
from
Arlington, VA
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
1122
mi
from
Arlington, VA
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Teva Investigational Site
1410
mi
from
Seattle, WA
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-102) for the Prevention of Pregnancy in Women
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
1410
mi
from
Seattle, WA
Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom
A Randomized Cross-Over Study of Vaginal Semen Exposure and Clinical Failure Comparing the PATH Woman's Condom and the FC2 Female Condom
Status: Archived
California Family Health Council
1172
mi
from
Los Angeles, CA
Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom
A Randomized Cross-Over Study of Vaginal Semen Exposure and Clinical Failure Comparing the PATH Woman's Condom and the FC2 Female Condom
Status: Archived
Updated: 1/1/1970
California Family Health Council
1172
mi
from
Los Angeles, CA
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
858
mi
from
Peoria, AZ
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
858
mi
from
Peoria, AZ
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
1320
mi
from
Santa Clara, CA
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
1320
mi
from
Santa Clara, CA
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
1143
mi
from
Celebration, FL
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
1143
mi
from
Celebration, FL
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
1444
mi
from
Boston, MA
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
1444
mi
from
Boston, MA
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
262
mi
from
Omaha, NE
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
262
mi
from
Omaha, NE
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
761
mi
from
Lima, OH
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
761
mi
from
Lima, OH
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
1357
mi
from
Medford, OR
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
1357
mi
from
Medford, OR
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
1225
mi
from
Philadelphia, PA
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
1225
mi
from
Philadelphia, PA
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
517
mi
from
Austin, TX
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
517
mi
from
Austin, TX
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Clinical Trial Facility
1413
mi
from
Mountlake Terrace, WA
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
1413
mi
from
Mountlake Terrace, WA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
853
mi
from
Phoenix, AZ
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
808
mi
from
Ann Arbor, MI
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
895
mi
from
Cleveland, OH
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
895
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
156
mi
from
Tulsa, OK
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
156
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1383
mi
from
Portland, OR
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1383
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1225
mi
from
Philadelphia, PA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
349
mi
from
Dallas, TX
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
349
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
779
mi
from
Salt Lake City, UT
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1181
mi
from
Norfolk, VA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1181
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1410
mi
from
Seattle, WA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1328
mi
from
Palo Alto, CA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1328
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1339
mi
from
San Francisco, CA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1135
mi
from
Vista, CA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1135
mi
from
Vista, CA
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
409
mi
from
Denver, CO
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
409
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
801
mi
from
Atlanta, GA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
843
mi
from
Idaho Falls, ID
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
843
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
610
mi
from
Chicago, IL
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
610
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
346
mi
from
Des Moines, IA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
346
mi
from
Des Moines, IA
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
726
mi
from
Cincinnati, OH
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
810
mi
from
Columbus, OH
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
810
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Magee-Womens Hospital, University of Pittsburgh
971
mi
from
Pittsburgh, PA
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Magee-Womens Hospital, University of Pittsburgh
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
569
mi
from
Houston, TX
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
569
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
418
mi
from
Saint Louis, MO
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
418
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1290
mi
from
New York, NY
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1290
mi
from
New York, NY
Click here to add this to my saved trials
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1043
mi
from
Chapel Hill, NC
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1043
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
Effect of Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding Continuation, Contraceptive Continuation, and Postpartum Depression: a Randomized Trial
Status: Enrolling
Updated:  12/31/1969
Center for Family Planning Research, Magee-Womens Hospital
971
mi
from
Pittsburgh, PA
Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
Effect of Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding Continuation, Contraceptive Continuation, and Postpartum Depression: a Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Center for Family Planning Research, Magee-Womens Hospital
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Early Postpartum Intrauterine Device (IUD) Placement
Early Versus Standard Interval Postpartum Intrauterine Device (IUD) Placement at 3 Weeks or 6 Weeks Following Delivery: A Prospective Randomized Trial
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
1383
mi
from
Portland, OR
Early Postpartum Intrauterine Device (IUD) Placement
Early Versus Standard Interval Postpartum Intrauterine Device (IUD) Placement at 3 Weeks or 6 Weeks Following Delivery: A Prospective Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
1383
mi
from
Portland, OR
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
402
mi
from
Aurora, CO
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
402
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1080
mi
from
Ocala, FL
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1080
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
499
mi
from
Decatur, IL
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
499
mi
from
Decatur, IL
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
715
mi
from
Fort Wayne, IN
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
715
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
568
mi
from
Newburgh, IN
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
568
mi
from
Newburgh, IN
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1179
mi
from
Easton, MD
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1179
mi
from
Easton, MD
Click here to add this to my saved trials